Feraccru (ferric maltol)
- Region
- 🇪🇺 EU
- Active substance
- ferric maltol
- Company
- Norgine B.V.
- Status
- Authorised
- Therapeutic area
- Anemia, Iron-Deficiency
- CHMP opinion
- Thu 17 Dec 2015
- EU approval
- Thu 18 Feb 2016
- Application
- EMEA/H/C/002733
- ATC
- B03AB
- Official record
- www.ema.europa.eu
Indication
Feraccru is indicated for the treatment of iron deficiency in adults and adolescents aged 12 years and older.
Regulatory milestones
No milestones recorded in the last year.
Follow Feraccru
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.